Lisinopril (Zestril)

Lisinopril, commonly known by the brand name Zestril, is an angiotensin-converting enzyme (ACE) inhibitor used in feline medicine for the management of cardiovascular disease, hypertension, and kidney-related conditions. While lisinopril is approved for human use, it is prescribed off-label for cats based on extensive veterinary clinical experience demonstrating its efficacy and safety in feline patients. This medication belongs to the same drug class as benazepril and enalapril, offering veterinarians another therapeutic option when managing cats with heart disease or elevated blood pressure. Lisinopril has become a valuable addition to the feline cardiovascular medication toolkit, particularly when other ACE inhibitors are unavailable or when individual patient factors favor its use.

The mechanism of action of lisinopril involves direct inhibition of the angiotensin-converting enzyme without requiring metabolic activation in the liver, distinguishing it from prodrug ACE inhibitors like enalapril. By blocking this enzyme, lisinopril prevents the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor hormone. The resulting vasodilation reduces both preload and afterload on the heart, decreasing the work required to pump blood throughout the body. This mechanism is particularly beneficial for cats with compromised cardiac function or elevated blood pressure. Additionally, lisinopril reduces aldosterone secretion, helping to decrease sodium and water retention that contributes to fluid accumulation in heart failure.

Lisinopril is available in tablet form in various strengths as well as an oral solution, providing flexibility for dosing cats of different sizes. The medication is typically administered once daily, making it convenient for long-term management of chronic conditions. Because lisinopril does not require hepatic activation to become effective, it may be advantageous for cats with liver dysfunction. The tablets are relatively small and can be administered using standard cat pilling techniques, hidden in treats or pill pockets, or given with food. The oral solution formulation allows for more precise dosing in smaller cats and may be easier to administer for some owners.

The safety profile of lisinopril in cats is generally comparable to other ACE inhibitors when used under appropriate veterinary supervision. Most cats tolerate the medication well, with serious adverse effects being uncommon at proper doses. However, because lisinopril is eliminated primarily through the kidneys, cats with significant renal impairment require careful dose adjustment and monitoring. Your veterinarian will assess your cat's overall health, including kidney function, before prescribing lisinopril and will establish a monitoring protocol to ensure safe and effective treatment. Regular follow-up appointments and blood work help optimize therapy and detect any potential problems early.

The primary indication for lisinopril in cats is the management of systemic hypertension, a condition that can cause serious damage to vital organs if left untreated. High blood pressure in cats often develops secondary to underlying diseases such as chronic kidney disease, hyperthyroidism, or primary hyperaldosteronism. Uncontrolled hypertension can lead to hypertensive retinopathy with acute blindness, cardiac complications including left ventricular hypertrophy, renal damage accelerating kidney disease progression, and neurological effects. Lisinopril works to lower blood pressure by causing blood vessel relaxation through ACE inhibition. The medication may be used alone or in combination with other antihypertensive agents such as amlodipine to achieve adequate blood pressure control.

Beyond hypertension management, lisinopril is prescribed for cats with various forms of heart disease, particularly when heart failure is present or impending. Congestive heart failure in cats most commonly results from hypertrophic cardiomyopathy but can also develop from dilated cardiomyopathy, restrictive cardiomyopathy, or valvular disease. Lisinopril helps manage heart failure by reducing cardiac workload through vasodilation and by decreasing fluid retention through aldosterone suppression. The medication is typically used as part of a comprehensive treatment protocol that may include diuretics such as furosemide and other cardiac medications. For cats with heart failure, ACE inhibitors like lisinopril can improve clinical signs and quality of life.

Lisinopril may be prescribed for cats with hypertrophic cardiomyopathy (HCM) even before overt heart failure develops. HCM is the most common cardiac disease in cats, characterized by abnormal thickening of the heart muscle that impairs filling and can eventually lead to heart failure or thromboembolism. While ACE inhibitors cannot reverse the structural changes of HCM, they may help reduce cardiac workload and potentially slow disease progression. The decision to initiate lisinopril in cats with HCM depends on disease severity, presence of complications such as left atrial enlargement, and individual patient factors. Regular echocardiographic monitoring helps guide treatment decisions in cats with cardiomyopathy.

Chronic kidney disease with proteinuria represents another important application for lisinopril in feline patients. Proteinuria, or excessive protein in the urine, is associated with faster progression of kidney disease and reduced survival times in cats with CKD. ACE inhibitors help reduce proteinuria by decreasing intraglomerular pressure, which reduces the filtration of protein across the damaged glomerular barrier. Lisinopril may slow the progression of kidney disease in proteinuric cats when used as part of comprehensive CKD management. However, because lisinopril is primarily eliminated by the kidneys, dose adjustments are necessary for cats with reduced kidney function, and other ACE inhibitors may be preferred in some cases.

Veterinarians choose lisinopril based on several factors including drug availability, cost, patient-specific considerations, and familiarity with the medication. Lisinopril's lack of requirement for hepatic activation makes it potentially suitable for cats with liver dysfunction. The availability of an oral solution formulation provides dosing flexibility for small cats or those difficult to pill. Because lisinopril is used off-label in cats, veterinarians rely on clinical experience and extrapolation from human and canine studies when establishing treatment protocols. Your veterinarian will determine whether lisinopril is the most appropriate ACE inhibitor for your cat's specific situation.

Dosing of lisinopril in cats is determined by your veterinarian based on thorough evaluation of your cat's condition, body weight, kidney function, and overall health status. Because lisinopril is used off-label in cats, dosing is based on clinical experience and published veterinary literature rather than FDA-approved feline labeling. Your veterinarian will calculate an appropriate dose considering the specific condition being treated, severity of disease, concurrent medications, and individual patient factors. Accurate body weight measurement is essential for proper dosing, and your cat should be weighed at each veterinary visit or at home using a reliable scale.

Typical dosing protocols for lisinopril in cats generally involve once-daily administration, although some veterinarians may prescribe twice-daily dosing based on the clinical situation. Starting doses are often conservative, with gradual increases as tolerated while monitoring blood pressure, kidney function, and clinical response. This careful titration approach helps minimize the risk of excessive blood pressure lowering while achieving therapeutic goals. Your veterinarian may adjust the dose over time based on your cat's response and any changes in health status. Maximum dose limits are determined individually considering the patient's kidney function and tolerance.

Treatment duration with lisinopril for chronic conditions such as hypertension, heart disease, or kidney disease is typically long-term or lifelong. These are chronic conditions that require ongoing management rather than short-term treatment. Discontinuing medication can lead to disease progression or acute decompensation, particularly for cats with heart failure. The duration of therapy depends entirely on your cat's underlying condition and response to treatment. Regular veterinary monitoring is essential throughout the treatment period to assess effectiveness, detect side effects, and make necessary adjustments. Your veterinarian will establish an appropriate follow-up schedule based on your cat's needs.

Lisinopril can be administered with or without food. Giving the medication at the same time each day helps maintain consistent drug levels and establishes a routine that makes administration easier to remember. Tablets can be hidden in pill pockets, small amounts of canned food, or soft treats. Direct pilling may be necessary for cats who detect and refuse hidden medications. The oral solution formulation allows for precise dosing using a syringe and may be easier to administer for some cats. If your cat is particularly difficult to medicate, discuss alternative formulations or administration strategies with your veterinarian.

If you miss a dose of lisinopril, administer it as soon as you remember on the same day. If it is almost time for the next scheduled dose, skip the missed dose and continue with the regular schedule. Never give a double dose to compensate for a missed one, as this could cause excessive blood pressure lowering or other adverse effects. Occasional missed doses are unlikely to cause significant harm, but consistent daily administration is important for optimal disease management. Consider setting reminders on your phone or linking medication time to a daily routine activity. Contact your veterinarian if multiple consecutive doses have been missed.

Completing prescribed treatment and continuing medication as directed is essential for chronic disease management. Never stop lisinopril or other cardiac medications abruptly without veterinary guidance, as this can precipitate acute heart failure or rapid blood pressure increases. If you have concerns about side effects, difficulty administering the medication, or treatment costs, discuss these openly with your veterinarian. Alternative approaches, different formulations, or other medications may be available. Your veterinarian is your partner in managing your cat's health and can help address treatment challenges while ensuring your cat receives appropriate care.

Lisinopril is generally well-tolerated in most cats when prescribed at appropriate doses with proper veterinary supervision. The majority of cats receiving lisinopril for cardiovascular disease or hypertension experience few if any adverse effects during treatment. Clinical experience with ACE inhibitors in feline medicine has established their overall favorable safety profile. However, as with any medication, side effects can occur, and cat owners should be informed about what to monitor during treatment. Early recognition of adverse effects allows for timely intervention and dose adjustment if needed.

The most commonly reported side effects of lisinopril in cats are mild gastrointestinal disturbances including decreased appetite, occasional vomiting, or soft stools. These effects are typically transient and often resolve as the cat adjusts to the medication. Administering lisinopril with food may help minimize stomach upset in sensitive cats. Some cats may show mild lethargy or reduced activity when first starting the medication, which usually improves within the first week or two of treatment. Weight loss associated with decreased appetite should be monitored, and persistent gastrointestinal symptoms warrant veterinary consultation.

Moderate side effects that require veterinary attention include signs of hypotension such as weakness, wobbling gait, lethargy, or fainting episodes. Because lisinopril is eliminated through the kidneys and affects renal hemodynamics, changes in kidney function may occur. Increases in blood urea nitrogen (BUN) and creatinine on blood work may indicate the need for dose adjustment or discontinuation in some cats. Changes in drinking and urination patterns may be observed. Some cats may develop skin reactions, although this is uncommon. Your veterinarian will monitor kidney parameters through periodic blood tests to detect any medication-related changes early.

Serious side effects requiring immediate veterinary attention are uncommon but possible. Signs of a severe allergic reaction include facial swelling, hives, difficulty breathing, or collapse and require emergency care. Acute kidney injury can occur in susceptible cats, particularly those who are dehydrated or have severely compromised baseline kidney function. Signs of acute kidney problems include sudden appetite loss, vomiting, extreme lethargy, or markedly decreased urination. Severe hypotension may manifest as collapse, profound weakness, pale or white gums, or cold extremities. Discontinue the medication and seek emergency veterinary care if your cat experiences any of these serious symptoms.

Rare side effects may include blood cell abnormalities, electrolyte imbalances such as elevated potassium (hyperkalemia), or liver enzyme elevations. Long-term use of lisinopril is generally safe with appropriate monitoring. Some cats may develop a dry cough while on ACE inhibitors, though this side effect is more commonly reported in dogs and humans. Your veterinarian will recommend periodic blood work to monitor kidney function, electrolytes, and other health parameters throughout treatment. Report any unusual symptoms or changes in your cat's behavior to your veterinarian, even if they seem minor or unrelated to the medication.

Lisinopril is contraindicated in cats with known hypersensitivity or allergic reactions to lisinopril or other ACE inhibitor medications. Any cat that has experienced adverse reactions to lisinopril, enalapril, benazepril, or other drugs in this class should not receive lisinopril. Allergic reactions may have manifested as facial swelling, hives, skin reactions, difficulty breathing, or anaphylaxis. Cross-reactivity between different ACE inhibitors can occur, meaning sensitivity to one drug in the class may predict reactions to others. Always inform your veterinarian of any previous adverse drug reactions your cat has experienced, including the specific medication involved and the nature of the reaction.

Cats with significant kidney dysfunction require careful evaluation before starting lisinopril therapy. Because lisinopril is eliminated almost entirely through the kidneys without hepatic metabolism, cats with severely reduced kidney function may accumulate the drug to potentially toxic levels. Lisinopril may be contraindicated in cats with acute kidney injury, severe chronic kidney disease, or end-stage renal failure. Your veterinarian will assess kidney function through blood tests measuring BUN, creatinine, and SDMA before prescribing lisinopril. For cats with moderate kidney impairment, dose reduction and close monitoring may allow safe use, but other ACE inhibitors with alternative elimination pathways may be preferred.

Lisinopril should not be administered to pregnant cats due to the known teratogenic effects of ACE inhibitors. These medications can cause serious fetal abnormalities and death when given during pregnancy. Female cats that could be pregnant or those intended for breeding purposes should not receive lisinopril. The safety of lisinopril in lactating queens has not been established, and the medication should generally be avoided during nursing due to potential excretion in milk and effects on nursing kittens. If ACE inhibitor therapy is essential for a lactating cat, weaning the kittens may be necessary before starting treatment. Safety in very young kittens has not been thoroughly studied.

Additional contraindications include certain cardiac conditions where ACE inhibitor therapy could be harmful. Cats with hemodynamically significant aortic stenosis may experience reduced coronary perfusion with vasodilator therapy. Cats with severe hypertrophic obstructive cardiomyopathy causing significant outflow tract obstruction may not be appropriate candidates. Severely hypotensive cats should not receive lisinopril as it may further reduce blood pressure to dangerous levels. Bilateral renal artery stenosis, while rare in cats, places patients at high risk for acute kidney failure with ACE inhibitor use. Severely dehydrated or volume-depleted cats should be stabilized before initiating therapy. Provide your veterinarian with a complete medical history to ensure lisinopril is safe for your cat.

Full disclosure of all medications, supplements, and over-the-counter products your cat receives is essential before starting lisinopril therapy. Drug interactions can significantly alter how lisinopril works in your cat's body, either reducing effectiveness or increasing the risk of adverse effects. Even seemingly harmless supplements, herbal products, or occasional medications can interact with ACE inhibitors. Keeping a comprehensive list of everything your cat takes ensures your veterinarian has complete information for safe prescribing. Always consult your veterinarian before adding any new medication or supplement while your cat is receiving lisinopril.

Significant drug interactions exist between lisinopril and several medication classes used in feline medicine. Concurrent use of multiple ACE inhibitors or combination with angiotensin receptor blockers (ARBs) is generally avoided due to increased risk of hypotension and acute kidney injury. Non-steroidal anti-inflammatory drugs (NSAIDs) can reduce the effectiveness of lisinopril for blood pressure control and increase nephrotoxicity risk when used together; if combination therapy is necessary, close monitoring is required. Potassium supplements and potassium-sparing diuretics may cause dangerous elevations in blood potassium when combined with ACE inhibitors. Loop diuretics like furosemide are commonly used with lisinopril in heart failure management but may enhance hypotensive effects, requiring careful dose adjustment.

Dietary factors and supplements may interact with lisinopril therapy. While lisinopril can be given with or without food without affecting absorption, certain dietary components are relevant. High-potassium diets or treats may contribute to hyperkalemia in cats receiving ACE inhibitors. Salt substitutes containing potassium chloride should be avoided. Supplements marketed for cardiac or renal support may contain active ingredients that interact with lisinopril, so all supplements should be reviewed with your veterinarian. Herbal preparations in particular may have unpredictable interactions with cardiovascular medications. Always verify safety before giving any new supplement to a cat on lisinopril.

Monitoring for drug interactions involves regular veterinary examinations, blood pressure measurements, and laboratory testing. Blood work evaluating kidney function, electrolytes (especially potassium), and other parameters helps detect interaction-related problems early. Signs that a drug interaction may be occurring include unexpected blood pressure changes, deteriorating kidney values, electrolyte imbalances, increased lethargy or weakness, or reduced therapeutic effectiveness. If you notice unusual symptoms after starting or stopping any medication while your cat is on lisinopril, contact your veterinarian promptly. Never add or discontinue medications without veterinary guidance when your cat is receiving ACE inhibitor therapy.

General precautions for lisinopril use in cats include ensuring accurate weight-based dosing, strict adherence to veterinary instructions, and commitment to regular monitoring appointments. Your cat should be weighed accurately before dosing calculations, and weight changes should be communicated to your veterinarian as they may necessitate dose adjustments. Never alter the prescribed dose without veterinary direction, even if you believe your cat's condition has changed. Store lisinopril safely away from pets and children, and use the medication only for the specific cat for whom it was prescribed. Never share cardiovascular medications between pets.

Breed-specific considerations are relevant for cats receiving lisinopril. Breeds with known predispositions to hypertrophic cardiomyopathy, including Maine Coons, Ragdolls, British Shorthairs, Persians, and Sphynx cats, may require ACE inhibitors as part of cardiac disease management and should be monitored closely. Siamese, Abyssinian, and Persian cats may have higher rates of kidney disease that could affect lisinopril elimination and require dose adjustment. Bengal cats have been reported to have sensitivities to certain medications, warranting careful monitoring. Your veterinarian considers breed background as part of the overall treatment evaluation, while recognizing individual variation within breeds.

Environmental and handling precautions are important for household safety. Store lisinopril tablets or solution in their original containers, protected from moisture, light, and temperature extremes. Wash hands after handling the medication. In multi-pet households, ensure only the intended patient receives the medication and that other animals cannot access it. Pregnant women should avoid handling lisinopril when possible due to the teratogenic potential of ACE inhibitors; if handling is necessary, wear gloves or wash hands thoroughly afterward. Contact poison control immediately if accidental human ingestion occurs.

Monitoring during lisinopril treatment should include both home observation and regular veterinary evaluation. At home, observe your cat's appetite, energy level, breathing pattern, and overall behavior. Watch for positive signs that the medication is working, such as improved activity or reduced respiratory effort. Also monitor for potential problems including excessive lethargy, weakness, vomiting, decreased appetite, or changes in water intake and urination. Your veterinarian will establish a monitoring schedule including blood pressure measurements and blood work to assess kidney function and electrolytes. Report any concerns to your veterinarian promptly.

Special populations requiring additional caution include geriatric cats, who often have age-related declines in kidney function that significantly affect lisinopril elimination. Older cats typically require lower doses and more frequent monitoring. Very young kittens have immature organ systems with limited safety data for lisinopril. Cats with multiple health conditions require individualized management considering all diagnoses and medications. Immunocompromised cats or those receiving chemotherapy should be evaluated individually. Cats with diabetes, liver disease, or other chronic conditions may need modified approaches. Always provide your veterinarian with complete information about your cat's health history and current conditions.

Proper storage of lisinopril is essential to maintain medication effectiveness and safety throughout the treatment period. Tablets should be stored at controlled room temperature, typically between 68°F and 77°F (20°C to 25°C), protected from excessive heat, cold, and moisture. Keep the medication in its original container with the cap tightly secured. Avoid storing lisinopril in bathrooms, kitchens, or areas with high humidity or temperature fluctuations. Do not expose the medication to direct sunlight or store it near heat sources. Tablets left in vehicles can be damaged by temperature extremes and should not be used.

Formulation-specific storage requirements differ between tablets and oral solutions. Standard lisinopril tablets are stable at room temperature when properly stored. The oral solution formulation may have different storage requirements, including potential refrigeration needs after opening; follow the specific instructions on the product label or provided by your pharmacist. Compounded formulations prepared by a compounding pharmacy typically have shorter expiration dates and may require refrigeration. Always check expiration dates before administering any medication, and do not use products past their labeled expiration. Inspect medications for signs of degradation such as discoloration, unusual odor, or changes in consistency before use.

Safe handling and disposal practices protect household members and the environment. Store lisinopril in a secure location inaccessible to children and pets; accidental ingestion can cause dangerous drops in blood pressure. This is particularly important for oral solutions, which may be more appealing to curious pets or children than tablets. Pregnant women should avoid direct contact with lisinopril due to known teratogenic effects; wearing gloves or thorough handwashing after handling is recommended. For disposal of unused or expired medication, utilize pharmacy or veterinary clinic drug take-back programs when available. If no take-back program exists, mix tablets with used coffee grounds, dirt, or cat litter in a sealed bag before placing in household trash, following current disposal guidelines. Do not flush medications down the toilet.

Most cats tolerate lisinopril well regardless of breed when the medication is properly prescribed and monitored. Lisinopril is used across all cat breeds and mixed-breed cats for appropriate cardiovascular and renal indications. However, breed-related factors may influence prescribing decisions, including predispositions to conditions treated with lisinopril and potential variations in drug metabolism or sensitivity. Your veterinarian considers breed as one factor among many in developing individualized treatment plans, while recognizing that individual patient characteristics often outweigh breed generalizations.

Certain purebred cat breeds have well-documented genetic predispositions to hypertrophic cardiomyopathy, the most common reason for prescribing ACE inhibitors for heart disease. Maine Coon cats have identified genetic mutations associated with HCM and may benefit from cardiac screening and early intervention. Ragdolls carry similar HCM-associated genetic variants. British Shorthairs, Persians, Sphynx, Bengal, and Devon Rex breeds show elevated HCM prevalence. For cats of these breeds diagnosed with cardiomyopathy, lisinopril may be part of a comprehensive management strategy. Regular echocardiographic screening is recommended for predisposed breeds to enable early disease detection.

Body size varies substantially among cat breeds and directly affects lisinopril dosing. Large breeds such as Maine Coons, Norwegian Forest Cats, and Ragdolls may require higher total doses to achieve therapeutic drug levels. Very small cats, including Singapuras and small individuals of any breed, require careful dose calculation to prevent excessive dosing. The oral solution formulation of lisinopril provides dosing flexibility for cats at size extremes where tablet strengths may not allow precise dosing. Accurate current body weight is essential for appropriate dosing regardless of breed or expected size.

Age-related factors interact with breed considerations in lisinopril therapy. Kittens have developing organ systems and limited safety data for ACE inhibitor use; lisinopril should be used cautiously if at all in very young cats. Senior cats are common candidates for lisinopril therapy due to increased prevalence of cardiac disease, hypertension, and kidney disease with age. Some breeds are associated with longer or shorter life expectancies, which may affect anticipated treatment duration. Breed-related health issues may result in earlier development of conditions requiring ACE inhibitor therapy. Your veterinarian will develop an individualized monitoring and treatment plan considering your cat's breed, age, and specific health needs.

Other ACE inhibitors used in feline medicine include benazepril (Fortekor), enalapril (Enacard), and ramipril. Benazepril is often preferred for cats with kidney disease because it undergoes both hepatic and renal elimination, whereas lisinopril is eliminated almost entirely through the kidneys. Enalapril was one of the earliest ACE inhibitors used in veterinary cardiology and remains commonly prescribed. Each ACE inhibitor has its own pharmacokinetic profile that may make it more or less suitable for individual patients. When a cat cannot tolerate one ACE inhibitor, switching to another in the same class may be attempted, though cross-sensitivity is possible. Your veterinarian will select the most appropriate ACE inhibitor based on your cat's specific conditions.

Alternative medication classes may be used instead of or in combination with lisinopril depending on the condition being treated. For hypertension, calcium channel blockers such as amlodipine (Norvasc) are often considered first-line therapy and are typically more effective than ACE inhibitors for blood pressure control in cats; combination therapy may be needed for resistant cases. Beta-blockers like atenolol are commonly prescribed for cats with hypertrophic cardiomyopathy to reduce heart rate and myocardial oxygen demand. Diuretics such as furosemide are essential for managing fluid accumulation in congestive heart failure. Angiotensin receptor blockers (ARBs) like telmisartan (Semintra) offer an alternative mechanism for cats who cannot tolerate ACE inhibitors, particularly for kidney disease management.

Complementary therapies may support cats receiving lisinopril for cardiac or renal disease. Omega-3 fatty acid supplements may provide cardiovascular and anti-inflammatory benefits. Prescription diets formulated for cardiac or renal support complement pharmaceutical management. Phosphate binders are often prescribed for cats with chronic kidney disease. Taurine supplementation may be important for certain cardiac conditions. Coenzyme Q10 (CoQ10) is sometimes recommended as a cardiac supplement. Never substitute any supplement or alternative therapy for prescribed lisinopril without explicit veterinary guidance. Always inform your veterinarian of all products your cat receives to ensure safe and coordinated care for your cat's cardiovascular or renal condition.